AI Biotechs with Real Clinical Momentum
The AI-first biotech sector is at a pivotal juncture. After years of substantial investment, bold claims of reinventing drug discovery, and a proliferation of sophisticated platforms, the industry is increasingly under scrutiny to deliver tangible results. The critical question is no longer about the potential of AI, but its proven ability to yield Investigational New […]
Breaking New Ground: Inside the Landmark Pfizer–3SBio Oncology Deal
The biopharma world is abuzz. In May 2025, Pfizer announced a deal that is being hailed as a watershed moment – not just for the companies involved, but for the entire innovation pipeline connecting East and West. With a headline figure of over $6 billion, this is the largest upfront ever for a China-developed oncology […]